First-derivative spectrophotometry in the analysis of rosiglitazone in coated tabletsGOMES, Patricia; STEPPE, Martin.Journal of AOAC International. 2006, Vol 89, Num 5, pp 1296-1299, issn 1060-3271, 4 p.Article

Effect of Rosiglitazone, a PPAR-γ Ligand on Haloperidol-Induced CatalepsyGUPTA, Gaurav; SINGH, Ramandeep; SHEBA RANI DAVID et al.CNS neuroscience & therapeutics (Print). 2013, Vol 19, Num 9, pp 724-725, issn 1755-5930, 2 p.Article

Evidence for a potent antiinflammatory effect of rosiglitazoneMOHANTY, Priya; ALJADA, Ahmad; GHANIM, Husam et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 6, pp 2728-2735, issn 0021-972X, 8 p.Article

ROSIGLITAZONE WHAT WENT WRONGCOHEN, Deborah.BMJ (Overseas and retired doctors ed.). 2010, Vol 341, Num 7772, pp 530-534, issn 1759-2151, 5 p.Article

Ineffectiveness of rosiglitazone therapy in nelson's syndromeMUNIR, A; SONG, F; INCE, P et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 5, pp 1758-1763, issn 0021-972X, 6 p.Article

Physiological Responses to Acute Psychological Stress Are Reduced by the PPARγ Agonist RosiglitazoneRYAN, Karen K; GRAYSON, Bernadette E; JONES, Kenneth R et al.Endocrinology (Philadelphia). 2012, Vol 153, Num 3, pp 1279-1287, issn 0013-7227, 9 p.Article

Rosiglitazone, marketing, and medical scienceMOYNIHAN, Ray.BMJ. British medical journal (International ed.). 2010, Vol 340, Num 7750, pp 785-788, issn 0959-8146, 4 p.Article

Effets cardiovasculaires de la rosiglitazone = Cardiovascular effets of rosiglitazoneLE FEUVRE, Claude.La Presse médicale (1983). 2004, Vol 33, Num 11, pp 735-745, issn 0755-4982, 11 p.Article

Rosiglitazone treatment reduces hippocampal neuronal damage possibly through alleviating oxidative stress in chronic cerebral hypoperfusionSAYAN-OZACMAK, Hale; OZACMAK, Veysel Haktan; BARUT, Figen et al.Neurochemistry international. 2012, Vol 61, Num 3, pp 287-290, issn 0197-0186, 4 p.Article

Topical Rosiglitazone Treatment Improves Ulcerative Col itis by Restori ng Peroxisome Proliferator-Activated Receptor-γ ActivityPEDERSEN, Gitte; BRYNSKOV, Jørn.The American journal of gastroenterology. 2010, Vol 105, Num 7, pp 1595-1603, issn 0002-9270, 9 p.Article

Rosiglitazone decreases 11 β-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissueMAI, Knut; ANDRES, Janin; BOBBERT, Thomas et al.Clinical endocrinology (Oxford. Print). 2007, Vol 67, Num 3, pp 419-425, issn 0300-0664, 7 p.Article

Rosiglitazone therapy of posttransplant diabetes mellitusVILLANUEVA, Griselda; BALDWIN, David.Transplantation. 2005, Vol 80, Num 10, pp 1402-1405, issn 0041-1337, 4 p.Article

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patientsMIYAZAKI, Y; GLASS, L; TRIPLITT, C et al.Diabetologia (Berlin). 2001, Vol 44, Num 12, pp 2210-2219, issn 0012-186XArticle

Thiazolidinediones : Données cliniques et perspectives = Thiazolidinediones : Clinical data and perspectivesBLICKLE, J. F.Diabetes & metabolism. 2001, Vol 27, Num 2, pp 279-285, issn 1262-3636, 2Article

Mechanical input restrains PPARγ2 expression and action to preserve mesenchymal stem cell multipotentialityCASE, Natasha; THOMAS, Jacob; ZHIHUI XIE et al.Bone (New York, NY). 2013, Vol 52, Num 1, pp 454-464, issn 8756-3282, 11 p.Article

Réflexions sur « l'affaire rosiglitazone »Médecine (Montrouge). 2010, Vol 6, Num 10, pp 478-482, issn 1777-2044, 5 p.Article

Rosiglitazone Is Associated with Mortality in Chronic Hemodialysis PatientsRAMIREZ, Sylvia P. B; ALBERT, Justin M; BLAYNEY, Margaret J et al.Journal of the American Society of Nephrology. 2009, Vol 20, Num 5, pp 1094-1101, issn 1046-6673, 8 p.Article

Rosiglitazone, a PPAR-γ Ligand, Reduces Burn Progression in RatsTAIRA, Breena R; SINGER, Adam J; MCCLAIN, Steve A et al.Journal of burn care & research. 2009, Vol 30, Num 3, pp 499-504, issn 1559-047X, 6 p.Article

Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events : The case of rosiglitazoneHERNANDEZ, Adrian V; WALKER, Esteban; IOANNIDIS, John P. A et al.The American heart journal. 2008, Vol 156, Num 1, pp 23-30, issn 0002-8703, 8 p.Article

Clinical implications of the DREAM study. CommentaryDAVIDSON, Mayer B.Diabetes care. 2007, Vol 30, Num 2, pp 418-420, issn 0149-5992, 3 p.Article

Placental transfer of rosiglitazone in the first trimester of human pregnancyCHAN, Louis Yik-Si; YEUNG, John Hok-Keung; TZE KIN LAU et al.Fertility and sterility. 2005, Vol 83, Num 4, pp 955-958, issn 0015-0282, 4 p.Article

Rosiglitazone treatment of diabetes mellitus after solid organ transplantationBALDWIN, David JR; DUFFIN, Karen E.Transplantation. 2004, Vol 77, Num 7, pp 1009-1014, issn 0041-1337, 6 p.Article

Systemic exposure to rosiglitazone is unaltered by foodFREED, M. I; ALLEN, A; JORKASKY, D. K et al.European journal of clinical pharmacology. 1999, Vol 55, Num 1, pp 53-56, issn 0031-6970Article

Dysfonction endothéliale et rosiglitazoneALBERTINI, J.-P.Archives des maladies du coeur et des vaisseaux. Pratique. 2007, Num 162, pp 8-8, issn 1261-694X, 1 p.Article

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapyKAHN, Steven E; HAFFNER, Steven M; VIBERTI, Giancarlo et al.The New England journal of medicine. 2006, Vol 355, Num 23, pp 2427-2443, issn 0028-4793, 17 p.Article